Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2008

Sanofi-Aventis Bids Against Anthiarose for Zentiva

  • Yesterday, Anthiarose, a subsidiary of PPF Group, reported a voluntary takeover offer to acquire Zentiva at $60.8 (CZK 950) a share.

    Today, Sanofi-Aventis, the largest Zentiva shareholder, presented a competing bid of $62.7 (CZK 1050) per share.

    Zentiva boasts over 280 products including prescription drugs, OTC products, and food supplements. The firm also manufactures cosmetics and APIs.


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »